Earnings per ordinary share for the quarter were NT$0.06. Earnings per ADS were US$0.010. The basic weighted average number of outstanding shares in 4Q13 was 12,476,082,332, compared with 12,459,978,088 shares in 3Q13 and 12,635,635,936 shares in 4Q12. The diluted weighted average number of outstanding shares was 13,243,379,446 in 4Q13, compared with 13,201,315,449 shares in 3Q13 and 13,379,741,687 shares in 4Q12. The fully diluted share count on December 31, 2013 was approximately 13,336,571,000. On December 31, 2013, UMC held 200 million treasury shares acquired from the 15th share buy-back programs.
Detailed Financials Section
Revenue decreased 8.0% QoQ to NT$30.72 billion from NT$33.41 billion in 3Q13, mainly due to decrease in ASP and wafer shipments. Total operating expenses increased by 8.6% to NT$5.32 billion. Sales and Marketing expenses increased 16.5% to NT$906 million mainly from increased IP and mask expenditures. Research & development expenses increased to NT$3.59 billion including year-end advanced tool maintenance expenditures and an increase in R&D wafers.
|
COGS & Expenses | |||||
|
(Amount: NT$ million) |
4Q13 |
3Q13 |
QoQ %
|
4Q12 |
YoY %
|
|
Net Operating Revenues |
30,719 |
33,407 |
(8.0) |
28,854 |
6.5 |
|
COGS |
(25,162) |
(26,070) |
(3.5) |
(25,629) |
(1.8) |
|
Depreciation |
(7,939) |
(8,151) |
(2.6) |
(7,516) |
5.6 |
|
Other Mfg. Costs |
(17,223) |
(17,919) |
(3.9) |
(18,113) |
(4.9) |
|
Gross Profit |
5,557 |
7,337 |
(24.3) |
3,225 |
72.3 |
|
Gross Margin (%) |
18.1% |
22.0% |
|
11.2% |
|
|
Operating Expenses |
(5,317) |
(4,894) |
8.6 |
(3,950) |
34.6 |
|
G&A |
(826) |
(854) |
(3.3) |
(783) |
5.5 |
|
Sales & Marketing |
(906) |
(778) |
16.5 |
(574) |
57.8 |
|
R&D |
(3,585) |
(3,262) |
9.9 |
(2,593) |
38.3 |
|
Net Other Operating Income & Expenses |
(46) |
(48) |
(4.2) |
(125) |
(63.2) |
|
Operating Income |
194 |
2,395 |
(91.9) |
(850) |
- |
